Review of Protocol. Company shall provide information regarding each protocol for each Study and agrees to allow CyDex to review and comment upon the aspects of such protocol which pertain solely to the use and administration of Captisol. Company shall give due consideration and reasonably incorporate any input that CyDex provides regarding such protocol to the extent it pertains solely to the use and administration of Captisol.
Appears in 3 contracts
Samples: License and Supply Agreement (Melinta Therapeutics, Inc. /New/), License and Supply Agreement (Rib-X Pharmaceuticals, Inc.), License and Supply Agreement (Rib-X Pharmaceuticals, Inc.)
Review of Protocol. Company shall provide information regarding each protocol pertaining solely to the use and administration of Captisol for each Study and agrees to allow CyDex to review and comment upon the aspects of such protocol which pertain solely to the use and administration of Captisol. Company shall give due consideration and reasonably incorporate **** any input that CyDex provides regarding such protocol to the extent it pertains solely to the use and administration of Captisol.
Appears in 3 contracts
Samples: License and Supply Agreement (Aldexa Therapeutics, Inc.), License and Supply Agreement (Aldexa Therapeutics, Inc.), License and Supply Agreement (Aldexa Therapeutics, Inc.)